Ownership history in MARSHALL WACE, LLP · 13 quarters on record
This page tracks every 13F SEC filing in which MARSHALL WACE, LLP reported a position in IMMUNOVANT INC (IMVT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 419,680 | +281,203 | +203.1% | 0.01% | $6.8M | $16.12 |
| 2025 Q1 | ADDED | 138,477 | +24,373 | +21.4% | 0.00% | $2.4M | $17.09 |
| 2024 Q3 | ADDED | 114,104 | +60,571 | +113.1% | 0.00% | $3.3M | $28.51 |
| 2024 Q1 | ADDED | 53,533 | +47,633 | +807.3% | 0.00% | $1.7M | $32.31 |
| 2023 Q3 | REDUCED | 5,900 | -33,053 | -84.9% | 0.00% | $227K | $38.39 |
| 2022 Q4 | ADDED | 38,953 | +30,637 | +368.4% | 0.00% | $691K | $17.75 |
| 2021 Q4 | REDUCED | 8,316 | -64,506 | -88.6% | 0.00% | $71K | $8.52 |
| 2021 Q3 | ADDED | 72,822 | +55,655 | +324.2% | 0.00% | $633K | $8.69 |
| 2021 Q2 | REDUCED | 17,167 | -4,027 | -19.0% | 0.00% | $181K | $10.57 |
| 2021 Q1 | ADDED | 21,194 | +15,739 | +288.5% | 0.00% | $340K | $16.04 |
As of 2025 Q4 — sorted by position size